Founded on the vision of Dr. Albert B. Sabin, we work to strengthen immunization in communities most affected by infectious diseases—with a focus on lower- and middle-income countries.
Collaboration is key to the development of real solutions that drive immunization and vaccine development. Sabin works with local and international partners to further vaccine access, acceptance, demand and innovation.
Our communities bring together experts across sectors and geographies to tackle urgent vaccine challenges.
Vaccines undergo rigorous testing for safety. Preclinical testing, clinical trials and regulatory approval processes ensure that vaccines are safe and effective before they’re given to children or adults.
Successful, sustainable immunization programs are a staple of health care worldwide. Vaccines are a best buy in global health, with economic and social benefits valued up to 44 times the cost of vaccination.
Childhood vaccines save more than 3 million lives each year and confer long-term immunity for most people. Vaccines have successfully controlled many diseases, ended smallpox, and are closing in on eradicating polio.
Vaccines do not only save lives, they change them. Vaccine-preventable diseases cause school absences, lost wages, birth defects and overburdened health systems. Continuing to develop new vaccines, removing barriers to access, countering misinformation and advocating for vaccine equity are critical to helping all communities realize the full benefits of immunization.
Make vaccines more accessible, enable innovation and expand immunization across the globe.